跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Telfast
Approved
STANDARD
Telfast
PT Aventis Pharma
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
42d84186609c5bc3
Company
PT Aventis Pharma
Type
Standard
Approval Details
Approval Id
42d84186609c5bc3
Drug Approval Philippines Name
Telfast
Product Name
Telfast
Registration Number
DRP-2108
Brand Name
Telfast
Generic Name
Fexofenadine Hydrochloride
Dosage Form
Tablet
Dosage Strength
180 mg
Manufacturer
PT Aventis Pharma
Importer
Sanofi-Aventis Philippines, Inc.
Issuance Date
24 January 2024
Expiry Date
30 January 2029
Pharmacologic Category
Antihistamine
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
42d84186609c5bc3
Type
Standard
Back to Philippines FDA Approvals